Oral Care Compositions Comprising Zinc Amino Acid Halides
US-2019015310-A1 · Jan 17, 2019 · US
US11186489B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11186489-B2 |
| Application number | US-201816206671-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 30, 2018 |
| Priority date | Dec 5, 2017 |
| Publication date | Nov 30, 2021 |
| Grant date | Nov 30, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein is zinc/amino acid functionalized silica, compositions comprising the same, and oral care methods and uses for such compositions.
Opening claim text (preview).
What is claimed: 1. A functionalized silica particle comprising a prophy silica having an average particle size of 5 to 20 microns; and a zinc-amino acid complex adsorbed to a surface of said silica, wherein the zinc-amino acid complex comprises zinc-lysine complex and/or zinc-arginine complex having a structure selected from one or more of [Zn(AA) 3 X] + , [Zn(AA) 2 X] + , [Zn(AA)X] + , [Zn(AA) 3 ] 2+ , [Zn(AA) 2 ] 2+ , [Zn(AA)] 2+ , wherein AA is lysine or arginine and wherein X is a halide, or another monovalent anion. 2. The functionalized silica particle according to claim 1 , wherein the zinc-amino acid complex comprises zinc-lysine complex having a structure selected from one or more of [Zn(AA) 3 X] + , [Zn(AA) 2 X] + , [Zn(AA)X] + , [Zn(AA) 3 ] 2+ , [Zn(AA) 2 ] 2+ , [Zn(AA)] 2+ , wherein AA is lysine, and wherein X is a halide or another monovalent anion. 3. The functionalized silica particle according to claim 1 , wherein the zinc-amino acid complex comprises zinc-arginine complex having a structure selected from one or more of [Zn(AA) 3 X] + , [Zn(AA) 2 X] + , [Zn(AA)X] + , [Zn(AA) 3 ] 2+ , [Zn(AA) 2 ] 2+ , [Zn(AA)] 2+ , wherein AA is arginine, and wherein X is a halide, or another monovalent anion. 4. The functionalized silica particle according to claim 2 wherein X is chloride. 5. The functionalized silica particle according to claim 1 , wherein the silica has an N 2 BET surface area of 200-1200 m 2 /g. 6. The functionalized silica particle according to claim 1 , wherein the silica has an N 2 BET surface area of 600 to 800 m 2 /g and an average particle size of 14 to 18 microns. 7. The functionalized silica particle according to claim 1 , wherein the functionalized silica contains from 0.1 to 10 mg of zinc/amino acid per 100 mg of silica. 8. The functionalized silica particle according to claim 1 , comprising from about 0.1 wt % to about 30 wt % zinc/amino acid, optionally wherein the zinc to amino acid molar ratio is from 5:1 to 1:5. 9. An oral care composition comprising a functionalized silica particle according to claim 1 . 10. The oral care composition according to claim 9 , wherein the composition comprises from 0.1 to 50% by weight of functionalized silica particles. 11. The oral care composition according to claim 9 , further comprising a metal salt. 12. The oral care composition according to claim 11 , wherein the metal salt comprises zinc oxide, zinc citrate, zinc lactate, zinc phosphate, or a combination thereof. 13. The oral care composition according to claim 9 , further comprising a basic amino acid, in free or orally acceptable salt form. 14. The oral care composition according to claim 9 , in the form of a toothpaste, gel, mouthwash, powder, cream, strip, thin film, or gum. 15. The oral care composition according to claim 14 , in the form of a toothpaste, gel or mouthwash. 16. The oral care composition according to claim 9 , further comprising an effective amount of a fluoride ion source. 17. A method of treating a disease, disorder or condition of the oral cavity, comprising the step of administering to a patient in need thereof an oral care composition according to claim 9 , to deliver zinc to the oral cavity, optionally, wherein said patient suffers from a disease, disorder or condition of the oral cavity, such as gingivitis, periodontitis, halitosis, cavity formation, enamel erosion, and/or oral infection. 18. The functionalized silica particle according to claim 4 , wherein the functionalized silica is made by incubating silica particles in an aqueous solution of a zinc-amino acid-halide complex having the structure [Zn(lysine) 2 Cl] + Cl −.
Porous; Hollow · CPC title
Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof (preparation of aerogels by dehydrating gels C01B33/158; treatment to enhance the pigmenting or filling properties C09C) · CPC title
Zinc; Compounds thereof · CPC title
Silicon; Compounds thereof · CPC title
Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.